Skip to main content

Table 2 Clinical and laboratory characteristics of the study patients

From: Dysregulation in growth arrest-specific 5 and metastasis-associated lung adenocarcinoma transcript 1 gene expression predicts diagnosis and renal fibrosis in systemic lupus erythematosus patients

Variables

Non nephritis

Nephritis

Total

p

Blood pressure

Average

18

85.7%

8

42.1%

26

65.0%

0.007*

Hypotensive

0

0.0%

0

0.0%

0

0.0%

Hypertensive

3

14.3%

11

57.9%

14

35.0%

UOP

Average

14

66.7%

5

26.3%

19

47.5%

< 0.001*

Anuria

1

4.8%

2

10.5%

3

7.5%

Oliguria

6

28.6%

11

57.9%

17

42.5%

Polyuria

0

0.0%

1

5.3%

1

2.5%

Proteinuria

No

20

95.2%

0

0.0%

20

50.0%

< 0.001*

Yes

1

4.8%

19

100.0%

20

50.0%

Casts in urine

None

19

90.5%

8

42.1%

27

67.5%

< 0.001*

Granular

1

4.8%

4

21.1%

5

12.5%

Hyaline

0

0.0%

1

5.3%

1

2.5%

Mixed “Granular&Hyaline”

1

4.8%

5

26.3%

6

15.0%

Crystal

0

0.0%

1

5.3%

1

2.5%

Relative expression of GAS5 (Median [IQR])

0.91 [0.42–1.28]

0.24 [0.17–0.67]

0.52 [0.19–1.02]

0.003*

Relative expression of MALAT1 (median [IQR])

3.58 [1.50–5.63]

2.60 [1.89–4.20]

3.13 [1.69–5.15]

0.25

Hb (mean ± SD)

9.3 ± 1.9

8.8 ± 2.0

9.1 ± 1.9

0.38

RBC (mean ± SD)

3,761,905 ± 763,869

3,584,211 ± 977,993

3,677,500 ± 865,305

0.52

WBC (median [IQR])

5600 [4400–9800]

6790 [5600–15,000]

6500 [4400–13,850]

0.27

Lymphocytes (median [IQR])

1300 [900–1700]

1400 [1000–1800]

1400 [950–1800]

0.66

PLT (median [IQR])

210,000 [135,000–295,000]

162,000 [12,7000–218,000]

203,500 [128,000–267,500]

0.15

S. creatinine (median [IQR])

0.9 [0.8–0.9]

1.5 [0.9–3.2]

0.9 [0.8–2.0]

0.004*

cNa (mean ± SD)

138.0 ± 4.5

138.6 ± 6.7

138.3 ± 5.6

0.73

ck (mean ± SD)

3.74 ± .56

3.81 ± .67

3.77 ± .61

0.71

ANA (median [IQR])

52.0 [40.0–93.5]

81.8 [45.0–133.0]

70.8 [41.1–99.0]

0.29

Anti.ds.DNA (median [IQR])

31.6 [9.9–68.0]

79.0 [20.0–210.0]

38.0 [15.0–161.8]

0.1

C3 (median [IQR])

76.0 [50.0–93.0]

77.0 [28.0–98.0]

76.5 [40.6–95.0]

0.76

C4 (median [IQR])

11.0 [8.0–22.0]

12.0 [7.0–29.4]

12.0 [7.5–27.1]

0.48

SLEDAI_2K.Score (median [IQR])

20.0 [14.0–29.0]

43.0 [28.0–55.0]

28.5 [19.5–48.0]

0.001*

Biopsy class

Non

0

0.0%

0

0.0%

0

0.0%

 

Class 1

0

0.0%

0

0.0%

0

0.0%

 

Class 2

0

0.0%

1

5.3%

1

5.3%

 

Class 3

0

0.0%

2

10.5%

2

10.5%

 

Class 4

0

0.0%

12

63.2%

12

63.2%

 

Class 5

0

0.0%

3

15.8%

3

15.8%

 

Class 4-5

0

0.0%

0

0.0%

0

0.0%

 

Class 6

0

0.0%

1

5.3%

1

5.3%

 

Biopsy.AI (median [IQR])

.

5.5 [5.0–8.0]

-

 

Biopsy.CI (median [IQR])

.

3.5 [1.5–6.0]

-

 
  1. Data are expressed as frequency (N, %), mean ± SD, and median (IQR). Test used: Fisher exact or Monte-Carlo for data expressed as frequency, Mann-Whitney U test for data expressed as median (IQR), and Student’s t test for data expressed as mean ± SD
  2. p p value
  3. *Significance < 0.05